$0.17 EPS Expected for Medidata Solutions Inc (MDSO)

July 18, 2017 - By Michael Collier

 $0.17 EPS Expected for Medidata Solutions Inc (MDSO)
Investors sentiment increased to 1.1 in 2016 Q4. Its up 0.09, from 1.01 in 2016Q3. It increased, as 28 investors sold Medidata Solutions Inc shares while 63 reduced holdings. 32 funds opened positions while 68 raised stakes. 56.66 million shares or 0.52% less from 56.95 million shares in 2016Q3 were reported.
Clearbridge Investments Lc holds 1.52M shares. 27,463 were accumulated by Wasatch. Atika Management Limited Co invested in 38,000 shares. Capstone Asset Management has invested 0.02% in Medidata Solutions Inc (NASDAQ:MDSO). Art Advisors Limited Liability holds 22,900 shares. Zurcher Kantonalbank (Zurich Cantonalbank) reported 1,978 shares. Raymond James Associate holds 0% of its portfolio in Medidata Solutions Inc (NASDAQ:MDSO) for 16,712 shares. Louisiana State Employees Retirement System has 0.06% invested in Medidata Solutions Inc (NASDAQ:MDSO) for 22,000 shares. Moreover, Tower Research Cap Limited Liability Company (Trc) has 0.01% invested in Medidata Solutions Inc (NASDAQ:MDSO). Geode Cap Mngmt Limited Com has 0.01% invested in Medidata Solutions Inc (NASDAQ:MDSO). Arizona State Retirement System has invested 0.02% in Medidata Solutions Inc (NASDAQ:MDSO). Proshare Advsrs Limited Liability Corp has 11,220 shares for 0.01% of their portfolio. 9,400 were accumulated by Hartwell J M Ltd Partnership. Frontier Cap Com Limited Liability has 248,873 shares. 7,200 were reported by Tocqueville Asset Mngmt L P.

Since January 25, 2017, it had 0 insider purchases, and 9 selling transactions for $3.63 million activity. 7,500 Medidata Solutions Inc (NASDAQ:MDSO) shares with value of $420,375 were sold by de Vries Glen Michael. Otner Michael I. also sold $559,200 worth of Medidata Solutions Inc (NASDAQ:MDSO) shares. On Monday, June 5 TAYLOR ROBERT sold $414,241 worth of Medidata Solutions Inc (NASDAQ:MDSO) or 5,639 shares. Hirschfeld Steven Isaac also sold $508,300 worth of Medidata Solutions Inc (NASDAQ:MDSO) shares. Sherif Tarek had sold 2,964 shares worth $169,185 on Tuesday, April 4. Capone Michael L also sold $347,300 worth of Medidata Solutions Inc (NASDAQ:MDSO) shares.

Analysts await Medidata Solutions Inc (NASDAQ:MDSO) to report earnings on July, 19. They expect $0.17 earnings per share, up 30.77 % or $0.04 from last year’s $0.13 per share. MDSO’s profit will be $10.05M for 119.12 P/E if the $0.17 EPS becomes a reality. After $0.20 actual earnings per share reported by Medidata Solutions Inc for the previous quarter, Wall Street now forecasts -15.00 % negative EPS growth. The stock decreased 0.94% or $0.77 during the last trading session, reaching $81. About shares traded. Medidata Solutions Inc (NASDAQ:MDSO) has risen 68.37% since July 18, 2016 and is uptrending. It has outperformed by 51.67% the S&P500.

Medidata Solutions Inc (NASDAQ:MDSO) Ratings Coverage

Among 14 analysts covering Medidata Solutions Inc. (NASDAQ:MDSO), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Medidata Solutions Inc. had 22 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was maintained by Topeka Capital Markets on Thursday, February 11 with “Buy”. The rating was maintained by Deutsche Bank on Tuesday, September 13 with “Buy”. The firm has “Hold” rating given on Friday, June 16 by Jefferies. Morgan Stanley maintained the stock with “Buy” rating in Wednesday, June 14 report. The company was initiated on Wednesday, September 9 by KeyBanc Capital Markets. Suntrust Robinson upgraded the stock to “Buy” rating in Friday, February 10 report. On Tuesday, April 26 the stock rating was initiated by Leerink Swann with “Market Perform”. The rating was maintained by Needham with “Buy” on Friday, February 10. The firm has “Underperform” rating by Jefferies given on Tuesday, April 26. Topeka Capital Markets maintained Medidata Solutions Inc (NASDAQ:MDSO) rating on Friday, September 25. Topeka Capital Markets has “Hold” rating and $53 target.

Medidata Solutions Inc. is a well-known provider of cloud solutions for life sciences. The company has market cap of $4.79 billion. The Firm provides cloud solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. It has a 142.58 P/E ratio. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

More important recent Medidata Solutions Inc (NASDAQ:MDSO) news were published by: Businesswire.com which released: “Medidata Reports Record Second Quarter 2017 Results” on July 18, 2017, also Streetinsider.com published article titled: “Medidata Solutions (MDSO) to Join S&P MidCap 400; McDermott International (MDR …”, Nasdaq.com published: “Medidata (MDSO), inVentiv Enter Into Multi-Year Partnership” on June 27, 2017. More interesting news about Medidata Solutions Inc (NASDAQ:MDSO) was released by: Nasdaq.com and their article: “Medidata Solutions (MDSO) Set to Join the S&P 400 Index” with publication date: June 21, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.